T Ruhstaller Selected Research

Neoadjuvant Therapy

1/2018

Neoadjuvant chemotherapy followed by chemoradiation and surgery with and without cetuximab in patients with resectable esophageal cancer: a randomized, open-label, phase III trial (SAKK 75/08).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

T Ruhstaller Research Topics

Disease

9	Breast Neoplasms (Breast Cancer) 10/2021 - 05/2006
8	Neoplasms (Cancer) 10/2021 - 07/2008
3	Adenocarcinoma 01/2018 - 04/2008
3	Carcinoma (Carcinomatosis) 01/2018 - 09/2009
2	Esophageal Neoplasms (Esophageal Cancer) 01/2018 - 09/2009
2	Disease Progression 01/2017 - 04/2011
2	Colorectal Neoplasms (Colorectal Cancer) 07/2008 - 05/2005
1	Amenorrhea 09/2017
1	Stomach Neoplasms (Stomach Cancer) 11/2010
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2009
1	Osteonecrosis (Kienbock's Disease) 12/2008
1	Exanthema (Rash) 07/2008
1	Rectal Neoplasms (Rectal Cancer) 04/2008

Drug/Important Bio-Agent (IBA)

3	Letrozole (Femara)FDA LinkGeneric 10/2021 - 04/2011
3	Hormones (Hormone)IBA 10/2021 - 10/2013
3	Capecitabine (Xeloda)FDA Link 11/2010 - 04/2008
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2008 - 05/2005
2	Cetuximab (Erbitux)FDA Link 01/2018 - 07/2008
2	Trastuzumab (Herceptin)FDA Link 01/2017 - 04/2011
2	Bevacizumab (Avastin)FDA Link 01/2011 - 12/2008
2	Cisplatin (Platino)FDA LinkGeneric 11/2010 - 09/2009
1	Estrogens (Estrogen)FDA Link 10/2021
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 09/2017
1	Triptorelin Pamoate (Trelstar)FDA Link 09/2017
1	palbociclibIBA 01/2016
1	lonaprisanIBA 10/2013
1	Progesterone Receptors (Progesterone Receptor)IBA 10/2013
1	Mifepristone (RU 486)FDA Link 10/2013
1	onapristoneIBA 10/2013
1	Aromatase InhibitorsIBA 04/2011
1	Estrogen ReceptorsIBA 04/2011
1	liposomal doxorubicin (Doxil)FDA Link 01/2011
1	1-dodecylpyridoxal (PLD)IBA 01/2011
1	matuzumabIBA 11/2010
1	Epirubicin (Ellence)FDA LinkGeneric 11/2010
1	Docetaxel (Taxotere)FDA Link 09/2009
1	taxaneIBA 09/2009
1	XELOXIBA 07/2008
1	Fluorouracil (Carac)FDA LinkGeneric 05/2005
1	Irinotecan (Camptosar)FDA LinkGeneric 05/2005
1	Leucovorin (Folinic Acid)FDA Link 05/2005

Therapy/Procedure

11	Therapeutics 09/2018 - 05/2006
5	Drug Therapy (Chemotherapy) 09/2017 - 09/2009
3	Radiotherapy 01/2014 - 04/2008
1	Neoadjuvant Therapy 01/2018
1	Adjuvant Chemotherapy 09/2017
1	Induction Chemotherapy 09/2009